SNWV SANUWAVE HEALTH INC revenue, earnings and financials

For the quarter ended June 30, 2026, SANUWAVE HEALTH INC reported revenue of $9.74M (down 3.1% from a year earlier), net income of −$682K and diluted EPS of −$0.08; over the last four quarters revenue was $44.0M and net income $15.3M; for the fiscal year ended December 2025 revenue was $44.1M, up 35.0% on the year before.

SNWV annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $44.1M, gross profit $34.0M, operating income $4.95M, net income $11.8M (margin 26.8%), EPS $0.41
• Fiscal year ended Dec 2024: revenue $32.6M, gross profit $24.6M, operating income $3.85M, net income −$33.1M (margin -101.4%), EPS −$7.41
• Fiscal year ended Dec 2023: revenue $20.4M, gross profit $14.4M, operating income −$540K, net income −$25.8M (margin -126.5%), EPS −$12.19
• Fiscal year ended Dec 2022: revenue $16.7M, gross profit $12.4M, operating income −$8.95M, net income −$10.3M (margin -61.5%), EPS −$0.02
• Fiscal year ended Dec 2021: revenue $13.0M, gross profit $8.02M, operating income −$14.1M, net income −$27.3M (margin -209.5%), EPS −$0.05

SNWV quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $9.74M (down 3.1% year over year), net income −$682K, EPS −$0.08
• Quarter ended Mar 31, 2026: revenue $9.62M (up 3.1% year over year), net income −$1.44M, EPS −$0.17
• Quarter ended Dec 31, 2025 (from the annual report): revenue $13.4M (up 29.7% year over year), net income $7.69M, EPS $0.78
• Quarter ended Sep 30, 2025: revenue $11.3M (up 20.4% year over year), net income $9.69M, EPS $0.39
• Quarter ended Jun 30, 2025: revenue $10.1M (up 40.4% year over year), net income $551K, EPS −$0.04
• Quarter ended Mar 31, 2025: revenue $9.33M (up 61.3% year over year), net income −$6.12M, EPS −$0.72
• Quarter ended Dec 31, 2024 (from the annual report): revenue $10.3M (up 47.6% year over year), net income −$13.3M, EPS −$0.76
• Quarter ended Sep 30, 2024: revenue $9.36M (up 89.0% year over year), net income −$21.2M, EPS −$6.65
• Quarter ended Jun 30, 2024: revenue $7.16M (up 53.2% year over year), net income $6.19M, EPS $0.00
• Quarter ended Mar 31, 2024: revenue $5.79M (up 53.3% year over year), net income −$4.80M, EPS $0.00
• Quarter ended Dec 31, 2023 (from the annual report): revenue $7.00M (up 27.2% year over year), net income $18.2M, EPS −$2.21
• Quarter ended Sep 30, 2023: revenue $4.95M (up 18.9% year over year), net income −$23.7M, EPS −$9.95
• Quarter ended Jun 30, 2023: revenue $4.68M (up 20.4% year over year), net income −$7.26M, EPS −$0.01
• Quarter ended Mar 31, 2023: revenue $3.78M (up 18.2% year over year), net income −$13.1M, EPS −$0.02
• Quarter ended Dec 31, 2022 (from the annual report): revenue $5.50M (up 29.1% year over year), net income −$5.70M, EPS −$0.01
• Quarter ended Sep 30, 2022: revenue $4.17M (up 11.8% year over year), net income −$1.14M, EPS $0.00
• Quarter ended Jun 30, 2022: revenue $3.88M (up 33.4% year over year), net income $1.64M, EPS $0.00
• Quarter ended Mar 31, 2022: revenue $3.20M (up 51.0% year over year), net income −$5.10M, EPS −$0.01
• Quarter ended Dec 31, 2021 (from the annual report): revenue $4.26M, net income −$9.46M, EPS −$0.01
• Quarter ended Sep 30, 2021: revenue $3.73M, net income −$4.25M, EPS −$0.01

SNWV cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $3.88M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow $2.46M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$4.54M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$17.2M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$6.41M, share buybacks n/a

SNWV balance sheet

• Jun 30, 2026: cash $9.38M, total assets $36.6M, total liabilities $33.8M, shareholders' equity $2.79M
• Mar 31, 2026: cash $10.8M, total assets $37.1M, total liabilities $35.3M, shareholders' equity $1.84M, long-term debt $14.8M
• Dec 31, 2025: cash $12.0M, total assets $37.3M, total liabilities $35.7M, shareholders' equity $1.62M, long-term debt $16.1M
• Sep 30, 2025: cash $9.60M, total assets $35.6M, total liabilities $43.2M, shareholders' equity −$7.59M, long-term debt $17.5M
• Jun 30, 2025: cash $8.50M, total assets $33.0M, total liabilities $51.8M, shareholders' equity −$18.8M
• Mar 31, 2025: cash $8.50M, total assets $30.9M, total liabilities $51.7M, shareholders' equity −$20.8M
• Dec 31, 2024: cash $10.2M, total assets $30.1M, total liabilities $45.9M, shareholders' equity −$15.8M
• Sep 30, 2024: cash $3.26M, total assets $21.8M, total liabilities $82.1M, shareholders' equity −$60.3M

What is SNWV's revenue?

SANUWAVE HEALTH INC reported $44.0M of revenue over its last four quarters, through June 30, 2026.

Is SNWV profitable?

Yes. SANUWAVE HEALTH INC earned $15.3M over the last four quarters.

What is SNWV's EPS?

Diluted earnings per share over the last four quarters were $0.92; −$0.08 in the latest quarter.

SNWV ownership and insider trades · All stocks